Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial.

Ann Transplant · 2021 · PMC7836319 · PMID 33479188

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

On the other hand, mTOR inhibitors, including EVL, are known diabetogenic drugs [ 18 , 27 – 29 ], and conversion from calcineurin inhibitors (CNI) to mTOR inhibitor even showed a trend toward increased risk of PTDM in KT recipients [ 30 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.